A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women

American Journal of Epidemiology

Volumn 175, Issue 1, 2012, Pages 22-32

  Margolis, Karen L ^a   Martin, Lisa W ^b   Ray, Roberta M ^c   Kerby, Tessa J ^a   Allison, Matthew A ^d   Curb, J David ^e   Kotchen, Theodore A ^f   Liu, Simin ^g   Wassertheil Smoller, Sylvia ^h   Manson, Joann E ⁱ  

^a HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

Author keywords

blood pressure; calcifediol; hypertension; prospective studies; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

DISEASE INCIDENCE; HEALTH RISK; HYPERTENSION; PHEROMONE; RECRUITMENT (POPULATION DYNAMICS); SERUM; VITAMIN; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; POSTMENOPAUSE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL;

AGED; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; VITAMIN D;

EID: 84555209158     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr274     Document Type: Article

References (33)

1. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110(2):229-238. (Pubitemid 34787360)
2. Zhou C, Lu F, Cao K, et al. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1a-hydroxylase knockout mice. Kidney Int. 2008; 74(2):170-179. (Pubitemid 351915078)
3. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27(10):1948-1954.
4. Feneis JF, Arora RR. Role of vitamin D in blood pressure homeostasis. Am J Ther. 2010;17(6):e221-e229.
5. Jorde R, Sneve M, Torjesen P, et al. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J InternMed. 2010; 267(5):462-472.
6. Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension. 2008;52(5):847-855.
7. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006; 354(7):669-683. (Pubitemid 43247138)
8. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49(5):1063-1069. (Pubitemid 351664326)
9. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52(5):828-832.
10. Griffin FC, Gadegbeku CA, Sowers MR. Vitamin D and subsequent systolic hypertension among women. Am J Hypertens. 2011;24(3):316-321.
11. Jorde R, Figenschau Y, Emaus N, et al. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010;55(3):792-798.
12. Ritenbaugh C, Patterson RE, Chlebowski RT, et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13(suppl 9):S87-S97. (Pubitemid 37324178)
13. Stefanick ML, Cochrane BB, Hsia J, et al. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(suppl 9):S78-S86. (Pubitemid 37324177)
14. Jackson RD, LaCroix AZ, Cauley JA, et al. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13(suppl 9):S98-S106. (Pubitemid 37324179)
15. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. Women's Health Initiative Investigators. N Engl JMed. 2006; 354(7):684-696. (Pubitemid 43247139)
16. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100(22):1581-1591.
17. Patterson RE, Kristal AR, Tinker LF, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9(3):178-187. (Pubitemid 29144458)
18. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25(1):71-80. (Pubitemid 23027685)
19. Mark SD, Katki HA. Specifying and implementing nonparametric and semiparametric survival estimators in two-stage (sampled) cohort studies with missing case data. J Am Stat Assoc. 2006;101(474):460-471. (Pubitemid 43972290)
20. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551-561. (Pubitemid 19116001)
21. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-511.
22. Melamed ML, Michos ED, Post W, et al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-1637.
23. Zittermann A, Frisch S, Berthold HK, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009; 89(5):1321-1327.
24. Forman JP,Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55(5):1283-1288.
25. Vaidya A, Forman JP,Williams JS. Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension. J Hum Hypertens. 2011;25(11):672-678.
26. Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions.Hypertension. 2010;56(5):774-779.
27. Mertens PR, Müller R. Vitamin D and cardiovascular risk. Int Urol Nephrol. 2010;42(1):165-171.
28. Giovannucci E. Vitamin D and cardiovascular disease. Curr Atheroscler Rep. 2009;11(6):456-461.
29. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152(5):307-314.
30. Wang L,Manson JE, Song Y, et al. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010;152(2):315-323.
31. Zittermann A, Gummert JF, Börgermann J. Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care. 2009; 12(6):634-639.
32. Wu-Wong JR. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol. 2009; 158(2):395-412.
33. Pilz S, Dobnig H, Nijpels G, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf). 2009;71(5): 666-672.